Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.
Saved in:
| Title: | Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis. |
|---|---|
| Authors: | Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, TN, 37203, USA, dyardley@tnonc.com., Noguchi S, Pritchard KI, Burris HA 3rd, Baselga J, Gnant M, Hortobagyi GN, Campone M, Pistilli B, Piccart M, Melichar B, Petrakova K, Arena FP, Erdkamp F, Harb WA, Feng W, Cahana A, Taran T, Lebwohl D, Rugo HS |
| Source: | Advances in therapy [Adv Ther] 2013 Oct; Vol. 30 (10), pp. 870-84. Date of Electronic Publication: 2013 Oct 25. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24158787 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yardley+DA%22">Yardley DA</searchLink>; Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, TN, 37203, USA, dyardley@tnonc.com.<br /><searchLink fieldCode="AU" term="%22Noguchi+S%22">Noguchi S</searchLink><br /><searchLink fieldCode="AU" term="%22Pritchard+KI%22">Pritchard KI</searchLink><br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink><br /><searchLink fieldCode="AU" term="%22Baselga+J%22">Baselga J</searchLink><br /><searchLink fieldCode="AU" term="%22Gnant+M%22">Gnant M</searchLink><br /><searchLink fieldCode="AU" term="%22Hortobagyi+GN%22">Hortobagyi GN</searchLink><br /><searchLink fieldCode="AU" term="%22Campone+M%22">Campone M</searchLink><br /><searchLink fieldCode="AU" term="%22Pistilli+B%22">Pistilli B</searchLink><br /><searchLink fieldCode="AU" term="%22Piccart+M%22">Piccart M</searchLink><br /><searchLink fieldCode="AU" term="%22Melichar+B%22">Melichar B</searchLink><br /><searchLink fieldCode="AU" term="%22Petrakova+K%22">Petrakova K</searchLink><br /><searchLink fieldCode="AU" term="%22Arena+FP%22">Arena FP</searchLink><br /><searchLink fieldCode="AU" term="%22Erdkamp+F%22">Erdkamp F</searchLink><br /><searchLink fieldCode="AU" term="%22Harb+WA%22">Harb WA</searchLink><br /><searchLink fieldCode="AU" term="%22Feng+W%22">Feng W</searchLink><br /><searchLink fieldCode="AU" term="%22Cahana+A%22">Cahana A</searchLink><br /><searchLink fieldCode="AU" term="%22Taran+T%22">Taran T</searchLink><br /><searchLink fieldCode="AU" term="%22Lebwohl+D%22">Lebwohl D</searchLink><br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2013 Oct; Vol. 30 (10), pp. 870-84. <i>Date of Electronic Publication: </i>2013 Oct 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24158787 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-013-0060-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 870 Titles: – TitleFull: Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yardley DA – PersonEntity: Name: NameFull: Noguchi S – PersonEntity: Name: NameFull: Pritchard KI – PersonEntity: Name: NameFull: Burris HA 3rd – PersonEntity: Name: NameFull: Baselga J – PersonEntity: Name: NameFull: Gnant M – PersonEntity: Name: NameFull: Hortobagyi GN – PersonEntity: Name: NameFull: Campone M – PersonEntity: Name: NameFull: Pistilli B – PersonEntity: Name: NameFull: Piccart M – PersonEntity: Name: NameFull: Melichar B – PersonEntity: Name: NameFull: Petrakova K – PersonEntity: Name: NameFull: Arena FP – PersonEntity: Name: NameFull: Erdkamp F – PersonEntity: Name: NameFull: Harb WA – PersonEntity: Name: NameFull: Feng W – PersonEntity: Name: NameFull: Cahana A – PersonEntity: Name: NameFull: Taran T – PersonEntity: Name: NameFull: Lebwohl D – PersonEntity: Name: NameFull: Rugo HS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2013 Oct Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 30 – Type: issue Value: 10 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |